IP Library › Granted Patent US 8,948,868
Granted Patent B2
US 8,948,868 · App. 11/554,825 · Granted Feb 3, 2015

Methods and apparatus for manually suspending intrathoracic impedance fluid status measurements

Inventors: Holly S. Vitense (Maple Grove, MN); Li Wang (Hong Kong, CN); Denise Dirnberger (Blaine, MN); Melissa M. Rhodes (Columbia Heights, MN); Douglas A. Hettrick (Andover, MN); Shantanu Sarkar (St. Paul, MN)
Assignee: Medtronic, Inc.
A61N1/37258A61B5/0031A61B5/0215A61B5/053A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,948,868
App. No.
11/554,825
Granted
Feb 3, 2015
Kind
B2
Abstract

The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.

Claims (12)

1. A method of selectively deactivating a notification function in an implantable medical device (IMD), comprising:

monitoring a physiologic parameter of a patient indicative of the patient's intrathoracic fluid status;

determining when the physiologic parameter one of exceeds a threshold and departs from a desired range;

energizing the notification function of the IMD responsive to a determination that the physiologic parameter one of exceeds a threshold and departs from a desired range;

receiving corrective or palliative therapy from a clinician subsequent to the determination that the physiologic parameter one of exceeds a threshold and departs from a desired range; and

deactivating the notification function of the IMD for a preset period of time responsive to receipt of the corrective or palliative therapy.

2. A method according to claim 1 , wherein the physiologic parameter comprises one of an intra-thoracic fluid parameter and a blood pressure parameter.

3. A method according to claim 1 , wherein the notification function provides one of an audible sound and a tactile sensation to the patient.

4. A method according to claim 1 , further comprising displaying the physiologic parameter and an indication of the status of the notification function on an external device programming unit.

5. A method according to claim 1 , further comprising:

continuing to monitor the physiologic parameter of the patient.

6. A method according to claim 1 , wherein the notification function includes wirelessly broadcasting a notification to an external receiver.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2007
From: VITENSE, HOLLY S.; WANG, LI; DIRNBERGER, DENISE; RHODES, MELISSA M.; HETTRICK, DOUGLAS A.; SARKAR, SHANTANU
To: MEDTRONIC, INC.
Reel/Frame 018840/0566 →
Continuity (1)
Related Publication 20080103530A1 · May 1, 2008